Streetbeat News

Stock Prices

CHRD

Chord Energy (NASDAQ:CHRD) received mixed analyst ratings, with 4 bullish and 4 somewhat bullish ratings. The average 12-month price target decreased by 6.75% to $199.56. Analysts adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Chord Energy showed strong financial performance with a 38.22% revenue growth rate, a 16.84% net margin, and a low debt-to-equity ratio of 0.14.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 2:00 pm

AR

Analysts have varied opinions on Antero Resources (NYSE:AR), with recent ratings showing a mix of bullish and neutral sentiments. The average 12-month price target has decreased by 7.54% to $34.83. Analysts have adjusted their ratings and price targets in response to market dynamics and company performance. Antero Resources faces challenges with below-industry-average net margin, ROE, and ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 2:00 pm

BTCUSD

Bitcoin has risen 8% in September, with traders optimistic about a strong Q4 performance. Historical trends and upcoming events, such as U.S. elections and FTX's $16 billion stimulus, are expected to create a favorable environment for Bitcoin. Analysts predict continued growth, with Bitcoin's market cap increasing and a potential breakout anticipated.

Portfolio Pulse from Khyathi Dalal

September 30, 2024 | 1:54 pm

SATS

EchoStar Corp (NASDAQ:SATS) shares fell after announcing DirecTV will acquire its video distribution business, including DISH TV and Sling TV, through a debt exchange. The deal aims to improve EchoStar's financial profile and focus on its 5G network. EchoStar also secured $2.5 billion in financing and plans to issue $5.1 billion in new senior secured notes.

Portfolio Pulse from Adam Eckert

September 30, 2024 | 1:50 pm

JNJ

LEGN

Legend Biotech and Johnson & Johnson announced positive three-year follow-up data from the Phase 3 CARTITUDE-4 study, showing that their partnered drug Carvykti significantly extends overall survival for multiple myeloma patients. This positions Carvykti as a leading cell therapy for lenalidomide-refractory multiple myeloma. The data supports its use in second-line treatment, with William Blair viewing it as a positive step for Legend Biotech.

Portfolio Pulse from Vandana Singh

September 30, 2024 | 1:47 pm

MEG

Jehoshaphat Research has released a report announcing a short position on Montrose Environmental Group (MEG). This could indicate potential downward pressure on MEG's stock price.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 1:46 pm

NFLX

Deep-pocketed investors are showing a bearish sentiment towards Netflix (NASDAQ:NFLX), with significant options activity detected. The options activity includes 6 puts and 6 calls, with a focus on a price range between $680 and $765. The stock is currently priced at $704.47, down 0.41%, and is approaching overbought levels according to RSI indicators. An analyst maintains a neutral rating with a target price of $635.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 1:46 pm

TSLA

Market whales have shown a bullish stance on Tesla (TSLA) options, with 157 call trades totaling $8.8 million and 27 put trades totaling $1.6 million. The targeted price range is $230 to $300. Despite a recent price dip, analysts have mixed ratings, with targets ranging from $24 to $310.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 1:45 pm

META

Financial giants have shown a bearish sentiment towards Meta Platforms, with 43% of options traders betting against the company. Despite this, analysts maintain positive ratings with price targets ranging from $600 to $645. Meta's stock is currently trading at $567.93, with an upcoming earnings announcement in 23 days.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 1:45 pm

EMKR

MOBX

Emcore Corporation's stock surged after Mobix Labs submitted an all-cash acquisition offer at $3.80 per share, a 200% premium over Emcore's previous closing price. Both companies are in the military and defense sector, and the acquisition is expected to enhance Mobix Labs' growth and innovation.

Portfolio Pulse from Erica Kollmann

September 30, 2024 | 1:44 pm